Literature DB >> 12505139

Herpesviruses and Toxoplasma gondii in orbital frontal cortex of psychiatric patients.

Concepcion Conejero-Goldberg1, E Fuller Torrey, Robert H Yolken.   

Abstract

Herpes simplex virus (HSV), Epstein-Barr virus (EBV), cytomegalovirus (CMV), and human herpesvirus-6 (HHV-6) are viruses capable of establishing latency. All of these infect the CNS and have been detected in human postmortem brains. Toxoplasma gondii is a protozoan organism which can reactivate in the brains of previously infected immunocompromised individuals. To screen for the presence of herpesviruses and T. gondii in postmortem orbital frontal brain samples from patients with schizophrenia, affective disorders, and controls, we used nested-polymerase chain reaction (n-PCR)/sequencing. We identified HHV-6B sequences in 2/51 postmortem brain samples but no sequences from other herpesviruses. We did not detect sequences of T. gondii in the postmortem brains. Additional studies including ones directed at the sensitive detection of viral nucleic acids in multiple brain regions should be directed at confirming or excluding a role for viruses and protozoa in the etiology of these disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12505139     DOI: 10.1016/s0920-9964(02)00160-3

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  14 in total

Review 1.  Cytomegalovirus and schizophrenia.

Authors:  E Fuller Torrey; Markus F Leweke; Markus J Schwarz; Norbert Mueller; Silke Bachmann; Johannes Schroeder; Faith Dickerson; Robert H Yolken
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 2.  Toxoplasmosis and neuropsychiatric diseases: can serological studies establish a clear relationship?

Authors:  Silvia Fabiani; Barbara Pinto; Fabrizio Bruschi
Journal:  Neurol Sci       Date:  2012-09-26       Impact factor: 3.307

3.  A controlled prospective study of toxoplasma gondii infection in individuals with schizophrenia: beyond seroprevalence.

Authors:  Dunja Hinze-Selch; Walter Däubener; Lena Eggert; Sükran Erdag; Renate Stoltenberg; Sibylle Wilms
Journal:  Schizophr Bull       Date:  2007-03-26       Impact factor: 9.306

Review 4.  Toxoplasma gondii infection and behaviour - location, location, location?

Authors:  Glenn A McConkey; Heather L Martin; Greg C Bristow; Joanne P Webster
Journal:  J Exp Biol       Date:  2013-01-01       Impact factor: 3.312

Review 5.  The human endogenous retrovirus link between genes and environment in multiple sclerosis and in multifactorial diseases associating neuroinflammation.

Authors:  Hervé Perron; Alois Lang
Journal:  Clin Rev Allergy Immunol       Date:  2010-08       Impact factor: 8.667

Review 6.  Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: cytomegalovirus, influenza, herpes simplex, rubella, and Toxoplasma gondii.

Authors:  C J Carter
Journal:  Schizophr Bull       Date:  2008-06-13       Impact factor: 9.306

7.  A forward phenotypically driven unbiased genetic analysis of host genes that moderate herpes simplex virus virulence and stromal keratitis in mice.

Authors:  Richard L Thompson; Robert W Williams; Malak Kotb; Nancy M Sawtell
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

8.  A sero-survey of toxoplasmosis in farm and non-farm children from Wisconsin, United States, 1997-1999.

Authors:  Claudia Muñoz-Zanzi; Jessica Williams-Nguyen; Edward A Belongia
Journal:  BMC Public Health       Date:  2013-09-11       Impact factor: 3.295

9.  Different presence of Chlamydia pneumoniae, herpes simplex virus type 1, human herpes virus 6, and Toxoplasma gondii in schizophrenia: meta-analysis and analytical study.

Authors:  José Gutiérrez-Fernández; Juan de Dios Luna Del Castillo; Sara Mañanes-González; José Antonio Carrillo-Ávila; Blanca Gutiérrez; Jorge A Cervilla; Antonio Sorlózano-Puerto
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-27       Impact factor: 2.570

Review 10.  Toxoplasma gondii and schizophrenia.

Authors:  E Fuller Torrey; Robert H Yolken
Journal:  Emerg Infect Dis       Date:  2003-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.